摘要
目的:痰热清辅助治疗在慢性阻塞性肺疾病急性发作期治疗中的临床疗效。方法:将2013年12月-2014年11月期间我院收治的慢性阻塞性肺疾病急性发作期患者94例为研究对象,随机将其均分成观察组和对照组,其中对照组采用常规治疗;观察组采用痰热清辅助治疗。对比分析两组患者的血气变化结果以及治疗效果。结果:治疗后,观察组患者PO2明显高于对照组,PCO2低于对照组(P<0.05),差异显著。观察组治疗总有效率为93.6%(44/47);对照组治疗总有效率为76.6%(36/47)。结论:在对慢性阻塞性肺疾病急性发作期患者进行治疗的同时,选择痰热清辅助治疗能够改善患者的通气功能,提升治疗效果,在临床中值得推广使用。
Objective： To observe clinical efficacy of Tanreqing on COPD during acute exacerbation. Methods： 94 cases were randomly divided into the observation group and control group, each group for 47 cases; the control group took conventional treatment; the observation group received Tartreqing. Results： After treatment, in the observation group, PO2 was obviously higher; the PCO2 was lower （P〈0.05）, with significant differences. The total efficiency was 93.6% （44/47） in the observed group and 76.6% （36/47） in the control group. Conclusion： Treating COPD during acute exacerbation with the adjuvant medicine of Tanreqing can improve the ventilation function and efficacy, is worthy of popularization.
出处
《中医临床研究》
2015年第35期75-76,共2页
Clinical Journal Of Chinese Medicine
